27-29 ao\u00fbt 2020
\nCongr\u00e8s virtuel<\/p>\n
ENYO Pharma \u00e9tait pr\u00e9sente du 27 au 29 ao\u00fbt 2020 au congr\u00e8s virtuel international sur le foie (EASL) et a pr\u00e9sent\u00e9 2 posters : <\/p>\n
“Characterization of EYP001 a novel, potent and selective FXR agonist in in vitro 3D human liver models”<\/p>\n <\/span>T\u00e9l\u00e9charger le poster (PDF)<\/span><\/a> \n <\/p>\n “A novel small molecule modulating the mitochondrial NEET (CISD) proteins activity improves inflammation and fibrosis in a diet-induced model of non-alcoholic steatohepatitis”<\/p>\n <\/span>T\u00e9l\u00e9charger le poster (PDF)<\/span><\/a> \n","protected":false},"excerpt":{"rendered":" 27-29 ao\u00fbt 2020 ENYO Pharma \u00e9tait pr\u00e9sente du 27 au 29 ao\u00fbt 2020 au congr\u00e8s virtuel international sur le foie (EASL) et a pr\u00e9sent\u00e9 2 posters : <\/p>\n “Characterization of EYP001 a novel, potent and selective FXR agonist in in vitro 3D human liver models”<\/p>\n<\/p>\n “A novel small molecule modulating the mitochondrial NEET (CISD) proteins activity improves inflammation and fibrosis in a diet-induced model of non-alcoholic steatohepatitis”<\/p>\n Lire la suite »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[12],"tags":[],"class_list":["post-3503","post","type-post","status-publish","format-standard","hentry","category-events-fr"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"editorENYOPharma","author_link":"https:\/\/www.enyopharma.com\/fr\/author\/editorenyopharma\/"},"rttpg_comment":0,"rttpg_category":"\u00c9v\u00e9nements<\/a>","rttpg_excerpt":"27-29 ao\u00fbt 2020 Congr\u00e8s virtuel ENYO Pharma \u00e9tait pr\u00e9sente du 27 au 29 ao\u00fbt 2020 au congr\u00e8s virtuel international sur le foie (EASL) et a pr\u00e9sent\u00e9 2 posters : “Characterization of EYP001 a novel, potent and selective FXR agonist in in vitro 3D human liver models” “A novel small molecule modulating the mitochondrial NEET (CISD)…","_links":{"self":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3503","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=3503"}],"version-history":[{"count":11,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3503\/revisions"}],"predecessor-version":[{"id":3521,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3503\/revisions\/3521"}],"wp:attachment":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=3503"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=3503"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=3503"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nCongr\u00e8s virtuel<\/p>\n